期刊： ACTA DIABETOLOGICA, 2022; 59 (8)
Aims Endoplasmic reticulum (ER) stress is associated with obesity and type 2 diabetes mellitus (T2DM) and increasing evidence demonstrates that some E......
期刊： ACTA DIABETOLOGICA, 2022; 59 (9)
Aim Cardiovascular disease (CVD) is a leading cause of death in both men and women. Type 1 and 2 diabetes mellitus (DM1 and DM2) are well-known risk f......
期刊： ACTA DIABETOLOGICA, 2022; 59 (11)
Aims To evaluate: (i) the propensity of paediatrics and emergency medicine residents to select different therapeutic options and (ii) the speed and ad......
期刊： ACTA DIABETOLOGICA, 2022; 59 (3)
Aims Diabetes retinopathy (DR) is associated with retinal microvascular system injury induced by high glucose (HG). This study aims to explore the rol......
期刊： ACTA DIABETOLOGICA, 2022; 59 (6)
Aims Albuminuria is strongly associated with risk of renal dysfunction, cardiovascular disease and mortality. However, clinical guidelines diverge, an......
期刊： ACTA DIABETOLOGICA, 2022; 59 (6)
Purpose To collate the effect of SGLT2 inhibitors (SGLT2i) on adverse gout events in people with type 2 diabetes mellitus (T2DM). Methods PubMed/MEDLI......
期刊： ACTA DIABETOLOGICA, 2022; 59 (8)
Aim There is little evidence of the impact of diabetes risk scores on individual diabetes risk factors, motivation for behaviour changes and mental he......
期刊： ACTA DIABETOLOGICA, 2022; 59 (11)
Aims (1) To describe the population of patients with type 1 diabetes (T1DM) using the rapid-acting insulin analogue glulisine versus lispro and aspart......
期刊： ACTA DIABETOLOGICA, 2022; 59 (12)
Aim We aimed to investigate the combined impact of liver enzymes and alcohol consumption on the diabetes risk. Methods Data on 5972 non-diabetic parti......
期刊： ACTA DIABETOLOGICA, 2022; 59 (12)
Aims To investigate the impact of SARS-COV-2 vaccination on the glycaemic control in children and adolescents with T1DM wearing continuous glucose mon......
期刊： ACTA DIABETOLOGICA, 2022; 59 (1)
Aims Molecular defects of hepatic nuclear factor 1 beta (HNF1 beta) are associated with multiorgan disease (renal disease, pancreatic hypoplasia, and ......
期刊： ACTA DIABETOLOGICA, 2022; 59 (2)
Aims To compare the influence of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and dipeptidyl peptidase-4 inhibitors (DPP-4i) on the risk of low......
期刊： ACTA DIABETOLOGICA, 2022; 59 (2)
Aims Atherogenic Index of Plasma (AIP) has been proposed as a novel marker of plasma atherogenicity, but its longitudinal predictive value in type 2 d......
